A person's degree of health and well-being depends on their underlying medical condition, and there are two treatment options for breast cancer in 2023: local and systemic. Depending on the circumstance, several therapeutic modalities are employed. When the cancer is localized, surgery is the mainstay of treatment for bosom disease. Chemotherapy for ER-positive tumors and adjuvant hormonal therapy (with tamoxifen or an aromatase inhibitor) come next. With each risk group following distinct treatment guidelines, a multidisciplinary team works to manage breast cancer in compliance with national and international legislation. Therapeutic outcomes include hormone therapy, chemotherapy, radiation therapy, and invulnerable treatments.
Track 8.1: Chemotherapy and Targeted Therapies
Track 8.2: Hormonal Therapy for Breast Cancer
Track 8.3: Immunotherapy Advancements
Track 8.4: Radiation Therapy Innovations
Track 8.5: Personalized Medicine in Breast Cancer Treatment
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
